Why Molnupiravir Fails in Hospitalized Patients

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has radically altered daily life. Effective antiviral therapies to combat COVID-19, especially severe disease, remain scarce. Molnupiravir is an antiviral that has shown clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Ashley N., Lang, Yinzhi, Zhou, Jieqiang, Franco, Evelyn J., Hanrahan, Kaley C., Bulitta, Juergen B., Drusano, George L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765607/
https://www.ncbi.nlm.nih.gov/pubmed/36374076
http://dx.doi.org/10.1128/mbio.02916-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765607/
https://www.ncbi.nlm.nih.gov/pubmed/36374076
http://dx.doi.org/10.1128/mbio.02916-22

Ejemplares similares